Clinical Trials · NCT04094415
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Italy, as Part of Local Clinical Practice
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 581
- Start date
- Oct 2019
- Locations
- 39 sites, Italy
- Primary endpoint
- Change in Glycated Haemoglobin A1c (HbA1c) (measured in percent)